Epigral Limited (NSE:EPIGRAL)

Epigral Revenue

Epigral had revenue of 7.05B INR in the quarter ending June 30, 2026, with 16.29% growth. This brings the company's revenue in the last twelve months to 26.26B, up 4.81% year-over-year. In the fiscal year ending March 31, 2026, Epigral had annual revenue of 25.27B, down -0.90%.

• Revenue (ttm): 26.26B
• Revenue Growth: +4.81%
• P/S Ratio: 1.82
• Revenue / Employee: 23.14M
• Employees: 1,135
• Market Cap: 47.75B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.27B	-229.50M	-0.90%
Mar 31, 2025	25.50B	6.21B	32.19%
Mar 31, 2024	19.29B	-2.59B	-11.84%
Mar 31, 2023	21.88B	6.37B	41.10%
Mar 31, 2022	15.51B	7.22B	87.18%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error